You are not logged in. (Log in | Create account | Contact Us | Bookmark Us)
logo
Clear Sky 14°
Clear Sky 
5 Day Forecast | Radar | Road Conditions
Celtics' Miles gets 10-game ban for drugs violation

September 20, 2008 - 12:00 a.m. EST

Photo
Click on photo to enlarge
Boston Celtics celebrate winning the NBA Finals basketball championship against the Los Angeles Lakers in Boston, June 17, 2008. REUTERS/Adam Hunger (UNITED STATES)

Boston Celtics celebrate winning the NBA Finals basketball championship against the Los Angeles Lakers in Boston, June 17, 2008. REUTERS/Adam Hunger (UNITED STATES)

NEW YORK (Reuters) - Boston Celtics forward Darius Miles has been given a 10-game suspension for violating the terms of the NBA's anti-drug program, the league said on Friday.

The NBA said the violation occurred at the end of the 2007-08 season and involved the amphetamine phentermine.

Miles was selected straight from high school by the Los Angeles Clippers as the third pick in the 2000 NBA Draft.

He played for two years with Los Angeles, two years with Cleveland and three years with Portland.

The 6-foot-9 (2.05 meter) forward, who has averaged 10.6 points and 5.2 rebounds in his career, has not played for two years due to a knee injury but was signed by the Celtics in August.

Miles' suspension will begin with the first game of the regular season.

(Writing by Steve Ginsburg in Washington)

Comments

Readers are solely responsible for the content of the comments they post here. Comments are subject to the site's terms and conditions of use and do not necessarily reflect the opinion or approval of True North Radio. Readers whose comments violate the terms of use may have their comments removed or all of their content blocked from viewing by other users without notification.

Post your comment

Commenting requires free alpenanow.com registration.

Username:
Password: (Forgotten your password?)

Comment:

 
ADVERTISEMENT


ADVERTISEMENT




Online Contents of this site are © Copyright 2008 Edwards Group. All rights reserved. See our terms of use for RSS feeds.